Skip Navigation
Home |Multimedia

Podcasts

Health Care
January 14, 2020
Discussion about FDA Reform (Guest: U.S. Congressman Mark Walker) Podcast
Christina Herrin, Director of Free to Choose Medicine with the Heartland Institute discusses the future of healthcare and FDA reform with U.S. Congressman Mark Walker who represents North Carolina's 6th Congressional District.
Health Care
January 6, 2020
The U.S. Primary Care Shortage (Guest: Courtney Joslin) Podcast
The Heartland Institute's health care policy advisor Sarah Lee interviews Courtney Joslin, resident fellow in commercial freedom at Washington, DC's R Street Institute, on how medical licensing reform can address the shortage in primary care physicians.
Health Care
January 2, 2020
Medical Tourism from Canada (Guest: Colin Craig) Podcast
Instead of going to Florida or some exotic locale for vacation, Canadians are flocking to other countries to get faster and better health care.

All Podcasts

  • Date
  • Topic
Clear All Filters
View  10  |  20  |  40
Health Care
January 14, 2020
Discussion about FDA Reform (Guest: U.S. Congressman Mark Walker)
By Christina Herrin
Christina Herrin, Director of Free to Choose Medicine with the Heartland Institute discusses the future of healthcare and FDA reform with U.S. Congressman Mark Walker who represents North Carolina's 6th Congressional District.
Tags
January 6, 2020
The U.S. Primary Care Shortage (Guest: Courtney Joslin)
By Sarah Lee
The Heartland Institute's health care policy advisor Sarah Lee interviews Courtney Joslin, resident fellow in commercial freedom at Washington, DC's R Street Institute, on how medical licensing reform can address the shortage in primary care physicians.
Tags
January 2, 2020
Medical Tourism from Canada (Guest: Colin Craig)
By AnneMarie Schieber
Instead of going to Florida or some exotic locale for vacation, Canadians are flocking to other countries to get faster and better health care.
Tags
December 31, 2019
Health Choices in 2020 (Guest: Michael Cannon)
By Sarah Lee
Michael Cannon, director of health policy studies at the Cato Institute, talks about the health care choices faces voters in the 2020 election and government-run health care doesn't hold a candle to federalism.
Tags
December 30, 2019
Advancing Reforms at the FDA
By Christina Herrin, Edward Hudgins
Free to Choose Medicine Director Christina Herrin discusses a recent FDA conference that Research Director Edward Hudgins attended where the topic was need to reform the payments system to a more value-based one and putting patients first.
Tags
December 24, 2019
Google May Now Have Your Private Medical Records (Guest: Twila Brase)
By AnneMarie Schieber, Twila Brase
Twila Brase of the Citizens Council for Health Freedom says it is time for a new rule that requires health care organizations to get explicit consent in any data sharing arrangement and sent a letter to U.S. Health and Human Services.
Tags
December 20, 2019
Omnibus Spending Bill Will Drive Up Health Care Costs (Guest: Brian Blase)
Galen Institute and Heritage Foundation Scholar Brian Blase says the Omnibus bill is a lost opportunity to control Obamacare’s runaway costs. Worse, it eliminates a revenue stream to fund the program, the Cadillac tax on higher cost employer health plans.
Tags
December 17, 2019
Non-Compete Clauses are Stopping Doctors from Serving Patients (Guest: Dr. Marcelo Hochman, Adam Habig)
By AnneMarie Schieber, Adam R. Habig
Increasingly, employers, mainly hospitals, are compelling physicians from signing long-term, restrictive non-compete clauses that go as far as prohibiting them from informing patients if they leave an organization and go elsewhere.
Tags
December 16, 2019
Diagnosing the Regulatory Pretzel Known as the FDA (Guest: Rik Mehta)
By Christina Herrin
Rik Mehta, biotech entrepreneur and candidate for Senate in New Jersey, discusses regulatory health care issues and what the future holds for medicine.
Tags
December 11, 2019
Controlling Drug Price Control (Guest: Jim Martin)
By Sarah Lee
The Heartland Institute's health care policy advisor Sarah Lee interviews Jim Martin of the 60 Plus Association on the anti-free-market policy idea of drug price controls to help address the worry over surprise billing.
Tags